Upcoming NIDDK R01: engineering stem cell-derived islet cells to improve diabetes cell replacement therapies
NIDDK plans a future R01 funding opportunity to support research that engineers stem cell-derived islet cell products to improve durability and function of diabetes cell-replacement therapies. It will encourage preclinical studies and collaborations across stem cell/islet biology, transplant immunology, and type 1 diabetes autoimmunity. This is a notice of intent; applications are not being ac…
Source
Award
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers